(1)
Tyrosine and Aurora Kinase Inhibitors Diminish Transport Function of Multidrug Resistance-Associated Protein (MRP) 4 and Breast Cancer Resistance Protein (BCRP). ADMET DMPK 2016, 4 (4), 302-313. https://doi.org/10.5599/admet.4.4.322.